These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women. Srisupandit S J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448 [TBL] [Abstract][Full Text] [Related]
9. Efficiency and acceptability of intrauterine contraceptive devices. Trutko NS Acta Med Hung; 1986; 43(2):103-8. PubMed ID: 3588154 [TBL] [Abstract][Full Text] [Related]
11. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial. Arowojolu AO; Otolorin EO; Ladipo OA Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202 [TBL] [Abstract][Full Text] [Related]
13. [The end of IUD marketing in the United States: what does it mean for American women?]. Forrest JD Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479 [TBL] [Abstract][Full Text] [Related]
14. [Translocation of intrauterine device (IUD) into the peritoneal cavity]. Andersen OP Ugeskr Laeger; 1980 Nov; 142(47):3132. PubMed ID: 7445223 [TBL] [Abstract][Full Text] [Related]
15. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study]. Zhuang L; Yang B; Yuan H Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880 [TBL] [Abstract][Full Text] [Related]
19. Safety of copper T as contraceptive after caesarean section. Parikh V; Gandhi AS J Indian Med Assoc; 1989 May; 87(5):113-5. PubMed ID: 2600433 [TBL] [Abstract][Full Text] [Related]
20. Autoerythrocyte sensitization worsened by a copper-containing IUD. Grossman RA Obstet Gynecol; 1987 Sep; 70(3 Pt 2):526-8. PubMed ID: 3627621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]